| 1 |
30489437 | Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper. | 2019 Jan |
1 |
| 2 |
31730560 | Potential of the Cardiovascular Drug Levosimendan in the Management of Amyotrophic Lateral Sclerosis: An Overview of a Working Hypothesis. | 2019 Nov |
1 |
| 3 |
29558109 | Reversible Covalent Reaction of Levosimendan with Cardiac Troponin C in Vitro and in Situ. | 2018 Apr 17 |
1 |
| 4 |
27673371 | Reversible Covalent Binding to Cardiac Troponin C by the Ca2+-Sensitizer Levosimendan. | 2016 Nov 1 |
8 |
| 5 |
25949787 | Effect of levosimendan on the contractility of muscle fibers from nemaline myopathy patients with mutations in the nebulin gene. | 2015 |
1 |
| 6 |
18570382 | Defining the binding site of levosimendan and its analogues in a regulatory cardiac troponin C-troponin I complex. | 2008 Jul 15 |
1 |
| 7 |
16181825 | Pharmacology of new agents for acute heart failure syndromes. | 2005 Sep 19 |
1 |
| 8 |
15646030 | The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c. | 2004 Nov |
4 |
| 9 |
12967628 | Interaction of levosimendan with cardiac troponin C in the presence of cardiac troponin I peptides. | 2003 Sep |
1 |
| 10 |
11113122 | Binding of levosimendan, a calcium sensitizer, to cardiac troponin C. | 2001 Mar 23 |
7 |
| 11 |
10731446 | Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of levosimendan. | 2000 Mar |
4 |
| 12 |
10446160 | Drug binding to cardiac troponin C. | 1999 Aug 20 |
3 |
| 13 |
9876999 | Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals. | 1998 Dec |
1 |
| 14 |
8523447 | Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. | 1995 Sep |
7 |
| 15 |
7961805 | Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. | 1994 Nov 18 |
9 |